Straight From the Cutter's Mouth
    Macular Disease, Retina/Vitreous
    CME 0.5 General AMA PRA Category 1 Credits™

    Drs. Mrinali Gupta and Ajay Kuriyan join for a group discussion of the April 2021 edition of Retinal Physician with a focus on macular degeneration and clinical trials. Discussion includes Complement Pathways for Dry AMD, Brolucizumab Real World Outcomes, Clinical Trial Adjustments with COVID-19, and Polypoidal Choroidal Vasculopathy

    CME Information

    Release: April 5, 2021; expires April 5, 2024

    Reviewers: Shriji Patel, MD

    Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

    Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

    Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

    Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.